Chemoinformaics analysis of luteolin-3-o-glucoside
| Molecular Weight | 448.38 | nRot | 4 |
| Heavy Atom Molecular Weight | 428.22 | nRig | 24 |
| Exact Molecular Weight | 448.101 | nRing | 4 |
| Solubility: LogS | -3.964 | nHRing | 2 |
| Solubility: LogP | 0.803 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 11 | APOL | 57.2279 |
| nHD | 7 | BPOL | 26.1401 |
| QED | 0.279 |
| Synth | 3.934 |
| Natural Product Likeliness | 2.076 |
| NR-PPAR-gamma | 0.552 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.963 |
| HIA | 0.676 |
| CACO-2 | -6.26 |
| MDCK | 0.0000103 |
| BBB | 0.018 |
| PPB | 0.908507 |
| VDSS | 0.786 |
| FU | 0.107812 |
| CYP1A2-inh | 0.356 |
| CYP1A2-sub | 0.059 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.035 |
| CYP2c9-sub | 0.383 |
| CYP2d6-inh | 0.212 |
| CYP2d6-sub | 0.205 |
| CYP3a4-inh | 0.118 |
| CYP3a4-sub | 0.019 |
| CL | 4.169 |
| T12 | 0.865 |
| hERG | 0.211 |
| Ames | 0.707 |
| ROA | 0.015 |
| SkinSen | 0.877 |
| Carcinogencity | 0.065 |
| EI | 0.268 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.858 |
| Antiviral | Yes |
| Prediction | 0.828969 |